Food allergy drug developer Alladapt raised $119M in new funding

The funding comes as the Menlo Park company has begun a clinical trial and is building a manufacturing plant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.